Geneva, March 20 -- International Clinical Trials Registry received information related to the study (KCT0011652) titled 'Early Detection of Concealed Cardiac Amyloidosis Using AI-ECG and CT-Derived Extracellular Volume in Patients with Atrial Fibrillation' on Feb. 25.
Study Type: Interventional Study
Study Design:
Primary Purpose : Diagnosis, Intervention Model : Parallel, Blinding/Masking : Open, Allocation : RCT
Primary Sponsor: Samsung Medical Center
Condition:
Endocrine, nutritional and metabolic diseases
Intervention:
Others(Early screening for cardiac amyloidosis via AI-ECG or CT-ECV) : The AI-enhanced electrocardiogram (AI-ECG) developed by Mayo Clinic is a tool that offers the potential for early, non-invasive screening ...